Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Long-term net clinical benefit in favor of...
Conference

Long-term net clinical benefit in favor of fondaparinux compared with enoxaparin in European patients with non-ST elevation acute coronary syndromes: a subgroup analysis of OASIS-5

Authors

Bassand J-P; Budaj A; Fox KAA; Mehta SR; Peters RJG; Steg PG; Wallentin L; Yusuf S

Volume

29

Pagination

pp. 327-328

Publisher

OXFORD UNIV PRESS

Publication Date

September 1, 2008

Conference proceedings

EUROPEAN HEART JOURNAL

ISSN

0195-668X